TTK Healthcare (BOM:507747) ROCE % : 7.34% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is TTK Healthcare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TTK Healthcare's annualized ROCE % for the quarter that ended in Dec. 2023 was 7.34%.

TTK Healthcare ROCE % Historical Data

The historical data trend for TTK Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTK Healthcare ROCE % Chart

TTK Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

17.06

8.71

8.61

8.73

10.31

TTK Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															7.25	11.55	8.96	9.12	7.34

TTK Healthcare ROCE % Calculation

TTK Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	668.745	/	( ( (5585.484 - 2205.344)	+	(11701.108 - 2107.799) )	/ 2 )
	=	668.745	/	( (3380.14	+	9593.309)	/ 2 )
	=	668.745	/	6486.7245
	=	10.31 %

TTK Healthcare's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	717.38	/	( ( (11822.762 - 2046.852)	+	(0 - 0) )	/ 1 )
	=	717.38	/	( ( 9775.91	+	0 )	/ 1 )
	=	717.38	/	9775.91
	=	7.34 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

TTK Healthcare (BOM:507747) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TTK Healthcare ROCE % Related Terms

Thank you for viewing the detailed overview of TTK Healthcare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

TTK Healthcare (BOM:507747) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTK Healthcare Ltd (BOM:507747) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

TTKHLTCARE:India

Address

No. 6, Cathedral Road, Chennai, TN, IND, 600 086

Website

https://www.ttkhealthcare.com

TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.

TTK Healthcare (BOM:507747) Headlines

No Headlines